Clinical Trials

Small Cell Lung Carcinoma

NCT03777124 2025-07-04

Phase II Study of SHR-1210(Anti-PD-1 Antibody) Combination With Apatinib Versus Pemetrexed and Carboplatin in Subjects With KRAS Mutant Stage IV Non-squamous Non-small Cell Lung Cancer

Phase 2 Terminated

25 enrolled

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07031154 2025-06-22

A Single-arm, Multicenter, Prospective Clinical Study of Adebrelimab Combined With Apatinib Neoadjuvant Therapy for Resectable Non-small Cell Lung Cancer

43 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06429696 2025-05-28

PD-L1 Inhibitor Combined With Apatinib as First-line Maintenance Treatment for Extensive-stage Small Cell Lung Cancer

Small Cell Lung Cancer Extensive Stage

NCT06483282 2025-04-15

A Study of Adebrelimab Combined With Apatinib Mesylate and Chemotherapy for Neoadjuvant Therapy and Biomarker Analysis in Limited-stage Small Cell Lung Cancer

38 enrolled

Phase 2 Not yet recruiting

Small Cell Lung Cancer Limited Stage

NCT06786312 2025-01-22

A Single-arm, Multicenter, Prospective Phase II Clinical Study of Apatinib in Combination With Adebrelimab and EC Regimen in the First-line Treatment of Extensive Small Cell Lung Cancer

34 enrolled

Small Cell Lung Carcinoma

NCT06749691 2024-12-27

LIAES

30 enrolled

Small Cell Lung Carcinoma

NCT03417895 2024-08-07

PASSION

59 enrolled 17 charts

Small Cell Lung Carcinoma

NCT06475209 2024-06-26

Adebrelimab + Apatinib in SCLC Maintenance Therapy

SCLC

NCT03190239 2024-02-28

XQonc-007

Phase 2 Withdrawn

Phase 2 Active not recruiting

Advanced Non-squamous Non-small-cell Lung Cancer

NCT04379739 2023-12-06

Neoadjuvant PD-1 Antibody Plus Apatinib or Chemotherapy for Non-small Cell Lung Cancer

89 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05932264 2023-07-06

Apatinib and Fluzoparib With or Without Adebrelimab in Previously-treated TP53-mutant Advanced Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

NCT04459078 2022-12-02

Clinical Study of Camrelizumab Combined With APatinib and Albumin Paclitacxel in Patients With Advanced Lung Adenocarcinoma

63 enrolled

Adenocarcinoma of Lung

NCT04749394 2022-08-16

A Study of Camrelizumab Plus Apatinib as Consolidation Therapy in Non-Small Cell Lung Cancer Patients Treated With Chemoradiotherapy

42 enrolled

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung

NCT02945852 2022-07-19

Apatinib for Extensive Stage Small Cell Lung Cancer After Second/Third Line Chemotherapy.

Small Cell Lung Carcinoma

NCT04901754 2021-12-08

CAMERA

38 enrolled

Small Cell Lung Carcinoma

NCT03256721 2021-02-08

Compare Apatinib Plus Chemotherapy Drug Versus Chemotherapy Drug as Second-line Treatment in NSCLC

Phase 2 Terminated

37 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04683198 2020-12-24

Camrelizumab Combined With Apatinib ,Carboplatin and Etoposide in Participants With ES-SCLC

69 enrolled

Small Cell Lung Carcinoma

NCT03547804 2020-12-01

MK 01

31 enrolled

Small Cell Lung Carcinoma

NCT04506242 2020-09-09

Camrelizumab With Apatinib as Neoadjuvant Therapy for Participants With Resectable Non-Small Cell Lung Cancer

74 enrolled

NSCLC

NCT03267654 2020-08-03

Gefitinib With Chemotherapy or Anti-angiogenesis in NSCLC Patients With Bim Deletion or Low EGFR Mutation Abundance

100 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03389087 2020-07-10

Study of Apatinib Plus Etoposide Capsule as the Therapy of Advanced Small Cell Lung Cancer

Small Cell Lung Carcinoma

NCT04453930 2020-07-01

A Study of Sequential Therapy of Camrelizumab Combined With Chemotherapy（Irinotecan Plus Platinum）and With Apatinib in Participants With Untreated Advanced Small Cell Lung Cancer（SCLC）

Small Cell Lung Carcinoma

NCT04425135 2020-06-11

Camrelizumab Combined With Apatinib Mesylate and Standard Chemotherapy (Pemetrixed + Carboplatin) in Patients With Tyrosine Kinase Inhibitor Failure in ALK-positive Advanced NSCLC

59 enrolled

Lung Neoplasms

NCT04128800 2019-10-16

Appatinib Combined With S-1 in the Treatment of Small Cell Lung Cancer

20 enrolled

Small Cell Lung Carcinoma

NCT03416231 2018-01-31

Apatinib Plus Docetaxel in Advanced Non-squamous Non-small Cell Lung Cancer(NSCLC)

20 enrolled

NSCLC

NCT03411967 2018-01-26

Apatinib in Combination With Docetaxel for Patients With Advanced NSCLC

20 enrolled

Lung Neoplasms

NCT03389256 2018-01-03

Apatinib in the Treatment of Patients With EGFR T790M-Negative NSCLC

144 enrolled

Lung Diseases, Neoplasms, Respiratory Tract Diseases, Thoracic Neoplasms

NCT03135977 2017-12-07

Apatinib and Etoposide as the Maintenance Therapy in Extensive-stage Small Cell Lung Cancer After First-line Chemotherapy

36 enrolled

Lung Neoplasms, Small Cell Lung Carcinoma

NCT02995187 2017-09-07

Study of Apatinib as Third-line and Later Therapy in Patients With Small Cell Lung Cancer (SCLC)

25 enrolled

Small Cell Lung Carcinoma

NCT02515435 2017-08-18

The Efficacy and Safety of Apatinib in Heavily Pretreated Advanced Non-squamous Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

NCT02980809 2016-12-02

Topotecan Plus Apatinib Versus Topotecan Alone as Second-line Therapy in Small-cell Lung Cancer

Small Cell Lung Carcinoma

NCT02733107 2016-04-12

The Efficacy and Safety of Apatinib Combined With Etoposide in Heavily Pretreated Advanced Non-small Cell Lung Cancer

25 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02704767 2016-03-10

Tarceva With or Without Apatinib in the Advanced Lung Adenocarcinoma

Phase 2 Active not recruiting

Lung Neoplasms

NCT02493582 2016-02-05

The Study of Apatinib Plus CIK as the Third Line Therapy for Advanced Lung Adenocarcinoma Patients With Wild-Type EGFR

400 enrolled

Adenocarcinoma of Lung

NCT02540824 2015-09-04

Study of Apatinib in RET Fusion Positive Advanced Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

NCT01270386 2012-02-10

A Study of Apatinib in Patients With Advanced Non-squamous and Non-small Cell Lung Cancer

136 enrolled